Gad Dairies After Weiler Closing: Lower Price, 2027 Profitability Drives the Earnout
The Weiler closing at NIS 42.8 million saves NIS 3.2 million versus the original price, but the added consideration mechanism shifts the debate to Weiler's ability to move from NIS 11.7 million of 2025 EBITDA toward the NIS 16.7 million 2027 earnout threshold.
The Weiler closing moves Gad Dairies from the question of whether the deal closes to a sharper question: how quickly the acquired asset can lift EBITDA. The immediate payment fell from NIS 46 million to NIS 42.8 million, a real improvement in cash use after a quarter in which cash and cash equivalents stood at NIS 57.9 million. That reduction does not by itself make the acquisition cheap, because the added consideration mechanism leaves sellers a path to receive more money if Weiler's 2027 EBITDA exceeds NIS 16.7 million. The story has therefore moved from a lower closing price to execution: can Weiler move from roughly NIS 11.7 million of 2025 EBITDA to a much higher profitability level within two years. Weiler's standalone numbers show a functioning and profitable asset, but also lower revenue and profitability versus 2024, so the required jump is not a straight continuation of the latest run-rate. The next proof points are performance around the NIS 12.7 million 2026 EBITDA target, exclusive distribution of Weiler products from July 1, 2026, and the purchase price allocation that will show how the deal enters the balance sheet.
The Price Fell by About 7% and the Cash Use Still Matters
The deal closed on April 30, 2026 as the acquisition of control, 51%, in Weiler Farm's activity, for consideration of about NIS 42.8 million. That is below the original NIS 46 million consideration, reducing the immediate payment by about NIS 3.2 million, roughly 7% of the original amount.
The reduction matters because it comes after a quarter in which the company held NIS 57.9 million in cash and cash equivalents, with no short-term deposits. This is not a full test of all-in cash flexibility after every cash use. It is a point-in-time comparison between the acquisition payment and cash at the end of March. Even after the reduction, the Weiler payment equals about 74% of that cash balance, so the discount eases the cash burden without making the acquisition a small balance-sheet event.
The revised price was set using a Weiler deal value of about NIS 84 million, based on NIS 11.7 million of 2025 EBITDA and the calculation of financial debt and working capital at the determining date. That detail matters more than the simple headline of a lower price: the consideration is no longer just a fixed number, but the output of profitability, debt, and working capital. In a food manufacturing business, where an acquisition has to translate into capacity, distribution, and margin, that is the right way to read the deal: less cash leaves at closing, but the final value depends on turning Weiler into a more profitable asset inside the group.
The 2027 EBITDA Threshold Returns Upside to the Sellers
The unusual part of the deal is not only the lower price. The revised consideration terms create a path in which the discount remains with the company if Weiler does not improve EBITDA enough, or partly returns to the sellers if execution improves sharply. The 2026 EBITDA target was updated to about NIS 12.7 million. If Weiler's 2027 EBITDA exceeds about NIS 16.7 million, the sellers will be entitled to additional consideration: about NIS 6.4 million, plus the refund amount, or part of it, if any amount is paid to the company for 2026 results.
The numerical gap sharpens the change. The 2025 deal base is about NIS 11.7 million of EBITDA. The 2026 target is about 9% above that base, while the 2027 earnout threshold is about 43% above it. Relative to the 2026 target, the 2027 threshold already requires an increase of about 32%. This is not a mechanism that sends cash back to sellers for a small improvement. It sends part of the value back only if Weiler quickly becomes a materially more profitable asset.
That is both supportive and demanding. The structure protects the company if Weiler remains near the 2025 base, and it also means the read on the acquisition has to move quickly from price to results. In the coming quarters, it will not be enough to see that the acquisition closed and Weiler entered the accounts. The relevant proof is whether distribution, development, and integration generate profitability that moves Weiler closer to the 2027 threshold.
Weiler's Standalone Results Keep the Deal in Execution Mode
The one-time disclosure of Weiler's standalone numbers gives a better reference point than investors had before closing. Weiler's revenue fell from NIS 59.9 million in 2024 to NIS 53.7 million in 2025, down about 10%. Operating profit fell from NIS 9.5 million to NIS 6.5 million, and net profit fell from NIS 6.8 million to NIS 4.8 million. The EBITDA line in the Weiler table also fell from NIS 11.6 million to NIS 9.1 million, while adjusted EBITDA fell from NIS 12.6 million to NIS 11.7 million.
The distinction between EBITDA and adjusted EBITDA is not cosmetic. The consideration mechanism closed around NIS 11.7 million, so the deal should be measured through the profitability metric on which the price terms are based. At the same time, the gap between NIS 9.1 million of EBITDA in the Weiler table and NIS 11.7 million of adjusted EBITDA means the profitability that will drive final consideration is not only a raw accounting number. It also depends on the adjustments presented by the company and on whether those adjustments become a recurring earnings base.
Distribution is where the next proof sits. The parties signed a distribution agreement under which the company will begin exclusively distributing Weiler products on July 1, 2026, and intends to integrate Weiler into the group's operations, distribution, and development platform. That can be the source of the improvement needed to justify the 2027 threshold, because plant-based food needs distribution, product development, and capacity utilization as much as it needs a good purchase price. At this stage, it remains a proof point, not a reported result. The purchase price allocation, which had not been completed when the financial statements were approved, will add an important accounting layer: how much of the price becomes goodwill and intangible assets, and what amortization or future impairment testing may follow.
Conclusion
The current read on Weiler has improved at the immediate cash layer and become more demanding at the execution layer. The company paid less at closing, but the revised mechanism does not reward it for a lower price alone. It shifts the center of gravity to 2026 and 2027 EBITDA, and especially to whether distribution and integration actually lift Weiler's profitability above the 2025 base. If Weiler stays close to NIS 11.7 million to NIS 12.7 million of EBITDA, the closing discount will look like sensible protection for the company. If it moves toward the NIS 16.7 million 2027 threshold, the added consideration to sellers will be less a problem and more evidence that the acquisition is beginning to deliver the profitability it was meant to buy.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.